Skip to main content
Year archive

BIOTRON LIMITED — 2023 filings

All 32 regulatory filings released by BIOTRON LIMITED (BIT) in 2023, sourced directly from the official regulator.

32 Filings
2023 Period
2023 filings (32)
Filing Released Lang
Shareholder Update 1 page 135.6KB
Regulatory Filings
2023-12-13 English
Application for quotation of securities - BIT 6 pages 27.6KB
Regulatory Filings
2023-11-30 English
Notification of cessation of securities - BIT 4 pages 23.7KB
Regulatory Filings
2023-11-26 English
Change of Director's Interest Notice MM 3 pages 218.3KB
Regulatory Filings
2023-11-26 English
Presentation to Annual General Meeting 14 pages 1.7MB
Regulatory Filings
2023-11-21 English
Results of AGM 2 pages 105.0KB
Regulatory Filings
2023-11-21 English
Application for quotation of securities - BIT 6 pages 27.6KB
Regulatory Filings
2023-11-09 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 1.1MB
Regulatory Filings
2023-10-26 English
Application for quotation of securities - BIT 6 pages 27.6KB
Regulatory Filings
2023-10-25 English
Presentation to Investors 14 pages 1.1MB
Regulatory Filings
2023-10-23 English
Annual Report/Notice of Annual General Meeting/Proxy Form 59 pages 1.5MB
Regulatory Filings
2023-10-19 English
Application for quotation of securities - BIT 6 pages 27.6KB
Regulatory Filings
2023-10-09 English
Response to ASX Price Query 3 pages 746.9KB
Regulatory Filings
2023-09-28 English
Letter to Shareholders 3 pages 390.6KB
Regulatory Filings
2023-09-25 English
Response to ASX Price Query 3 pages 692.7KB
Regulatory Filings
2023-09-10 English
Full Year Statutory Accounts and Appendix 4E 53 pages 1.2MB
Regulatory Filings
2023-08-24 English
Corporate Governance Statement 9 pages 250.5KB
Regulatory Filings
2023-08-24 English
Appendix 4G 13 pages 314.9KB
Regulatory Filings
2023-08-24 English
COMPLETION OF PHASE 2 COVID CLINICAL TRIAL 2 pages 320.7KB
Regulatory Filings
2023-08-15 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 572.3KB
Regulatory Filings
2023-07-27 English
Second Site Approved for Phase 2 Covid-19 Trial 2 pages 95.5KB
Regulatory Filings
2023-05-11 English
Commencement Phase 2 Covid-19 Clinical Trial 4 pages 156.2KB
Regulatory Filings
2023-05-03 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 1.1MB
Regulatory Filings
2023-04-26 English
Application for quotation of securities - BIT 6 pages 27.6KB
Regulatory Filings
2023-03-21 English
Cleansing Notice 1 page 98.5KB
Regulatory Filings
2023-03-21 English
Completion of Phase 2 HIV-1 Clinical Trials 2 pages 412.7KB
Regulatory Filings
2023-03-08 English
International Presentation of BIT225 COVID-19 Data 3 pages 748.4KB
Regulatory Filings
2023-02-20 English
Half Yearly Report and Accounts 23 pages 808.2KB
Regulatory Filings
2023-02-16 English
Notification of cessation of securities - BIT 4 pages 24.1KB
Regulatory Filings
2023-01-31 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 378.2KB
Regulatory Filings
2023-01-30 English
Application for quotation of securities - BIT 6 pages 27.6KB
Regulatory Filings
2023-01-24 English
CLEANSING NOTICE 1 page 266.1KB
Regulatory Filings
2023-01-24 English